A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2011
12/08/2011	WO2011152783A1 Formulations preserving bioactivity and methods of their preparation
12/08/2011	WO2011152730A2 Stable high lipid liquid formula
12/08/2011	WO2011152707A1 Stable high lipid liquid formula
12/08/2011	WO2011152662A2 Ptd-uqcrb fusion polypeptide, and pharmaceutical composition for preventing and treating ischemic diseases, containing same
12/08/2011	WO2011152618A2 Non-diffusive botulinum toxin causing local muscle paralysis, and purification method thereof
12/08/2011	WO2011152524A1 Cell growth-promoting peptide and use thereof
12/08/2011	WO2011152330A1 Soybean protein hydrolysate-containing antioxidant and use thereof
12/08/2011	WO2011152071A1 Novel hyaluronic acid decomposition-promoting factor and inhibitor thereof
12/08/2011	WO2011151835A1 A novel synergistic pharmaceutical composition for topical applications
12/08/2011	WO2011151833A1 Methods of treating diabetes and compositions capable of same
12/08/2011	WO2011151798A1 Compositions for use in the treatment or diagnosis of prion diseases
12/08/2011	WO2011151782A1 A role for somatostatin to modulate initiation of follicular growth in the human ovary
12/08/2011	WO2011151407A1 Fraction of proteins and peptides derived from egg white and protein derived from egg white and use thereof as anti-listeria agent
12/08/2011	WO2011151403A1 Improved cancer therapy based on tumor associated antigens derived from cyclin d1
12/08/2011	WO2011151400A1 Process for making dry and stable hemostatic compositions
12/08/2011	WO2011151384A1 Process for making dry and stable hemostatic compositions
12/08/2011	WO2011150944A1 Trefoil factors (tff) for the treatment of chronic pulmonary diseases
12/08/2011	WO2011150517A2 Biomarker for diagnosis and treatment of colorectal cancer
12/08/2011	WO2011150516A1 Diagnostic, screening and therapeutic applications of ocab-based tools
12/08/2011	WO2011150500A1 Cyclic amino acid molecules containing aziridine amino acids and methods of preparing same
12/08/2011	WO2011150495A1 Rhamm binding peptides
12/08/2011	WO2011150482A1 Methods for obtaining reabsorbable composites, composites, membrane, scaffold and its uses
12/08/2011	WO2011150470A1 Vitronectin:keratinocyte growth factor chimeras
12/08/2011	WO2011113065A3 Pegylated polyplexes for polynucleotide delivery
12/08/2011	WO2011112999A3 Lipid-peptide-polymer conjugates and nanoparticles thereof
12/08/2011	WO2011103666A8 Modulation of cytokine-induced chronic inflammatory responses
12/08/2011	WO2011103599A9 Epithelial membrane protein 2 (emp2) binding reagents and their therapeutic uses in ocular diseases
12/08/2011	WO2011102999A3 Spink1 targeted therapy
12/08/2011	WO2011100460A3 Ccr7 ligand delivery and co-delivery in immunotherapy
12/08/2011	WO2011097381A8 Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations therof
12/08/2011	WO2011083500A3 Method of use of stabilized plant-derived growth factor in skin care
12/08/2011	WO2011053991A3 Vault complexes for cytokine delivery
12/08/2011	WO2010102148A3 An improved dry powder drug delivery system
12/08/2011	US20110302675 Control of viral and bacterial infection by antimicrobial peptides retrocylin and/or protegrin expressed in chloroplasts
12/08/2011	US20110301525 Biomaterials for tissue replacement
12/08/2011	US20110301339 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
12/08/2011	US20110301338 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
12/08/2011	US20110301337 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
12/08/2011	US20110301220 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)
12/08/2011	US20110301219 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)
12/08/2011	US20110301102 Compositions and methods for treating myelodysplastic syndrome
12/08/2011	US20110301101 T cell immune balance peptides
12/08/2011	US20110301100 Pharmaceutical Compositions Comprising Polyethylene Glycol Having a Molecular Weight of Less Than 600 Daltons
12/08/2011	US20110301099 Method for enhancing penetration of lipid insoluble medicaments through cell membranes using small S-Allyl-containing molecules with phospholipid permeability as carrier molecules
12/08/2011	US20110301098 Treatment for intimal hyperplasia and related conditions
12/08/2011	US20110301096 Prodrug of an ice inhibitor
12/08/2011	US20110301095 Methods and compositions for assessing and treating metastasis, metastatic cancer, and potential for metastasis
12/08/2011	US20110301094 New tumor suppressor gene, p28ing5
12/08/2011	US20110301093 Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to beclin-1
12/08/2011	US20110301092 The use of a non-glycanated polypeptide for treating a cancer
12/08/2011	US20110301091 Compositions and methods for reducing the signs of aging of the skin
12/08/2011	US20110301090 Skin wound healing compositions and methods of use thereof
12/08/2011	US20110301089 Adiponectin receptor fragments and methods of use
12/08/2011	US20110301088 Crystalline ezatiostat hydrochloride ansolvate
12/08/2011	US20110301087 Crf1 receptor compounds
12/08/2011	US20110301086 Complex polymere amphiphile-PDGF
12/08/2011	US20110301085 Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis
12/08/2011	US20110301084 Protracted Exendin-4 Compounds
12/08/2011	US20110301083 Conjugate based systems for controlled drug delivery
12/08/2011	US20110301082 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
12/08/2011	US20110301081 Long-acting formulations of insulins
12/08/2011	US20110301080 Pharmaceutical compositions
12/08/2011	US20110301079 Neuromedin u receptor agonists and uses thereof
12/08/2011	US20110301078 Prevention of bacterial growth and biofilm formation by ligands that act on cannabinoidergic systems
12/08/2011	US20110301077 Method for production of lactoferrin
12/08/2011	US20110301076 Antimicrobial compounds
12/08/2011	US20110301075 Use of BBI/BBIC for Treatment of Muscular Atrophy and Degenerative Muscle Disease
12/08/2011	US20110301074 Protein preparation produced from rape seeds
12/08/2011	US20110301073 Novel DNA-binding proteins and uses thereof
12/08/2011	US20110300600 Methods and compositions for delivering polynucleotides
12/08/2011	US20110300578 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
12/08/2011	US20110300577 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
12/08/2011	US20110300245 Topical, palatable, anti-inflammatory and analgesic for specific application to intraoral, gingival and extraoral areas correlated with, and related to, the trigeminal nerve and its nerve branches and plexus. To mitigate, attenuate or prevent migraine-type headache, cluster-type headache, tension-type headache, post-traumatic headache, atypical facial pain and cervical muscle spasm as well as other idiopathic head or facial pain or discomfort, associated with, or exacerbated by, inflammation
12/08/2011	US20110300234 Methods of Treating Tumor Cells Using RHCC Protein, Fragment or Variant
12/08/2011	US20110300232 EFFECTS OF NITRIC OXIDE (NO) AND iNOS ON EXPRESSION AND SIGNAL TRANSDUCTION IN CANCER AND ITS USE IN DRUG DISCOVERY AND CANCER THERAPY DESIGN
12/08/2011	US20110300229 Treating or preventing rotavirus infection
12/08/2011	US20110300215 Tablet formulation of ezatiostat
12/08/2011	US20110300203 Cartilage regeneration without cell transplantation
12/08/2011	US20110300199 Peptides used in the treatment and/or care of the skin, mucous membranes and/or scalp and their use in cosmetic or pharmaceutical compositions
12/08/2011	US20110300195 Ophthalmic Compositions Comprising Calcineurin Inhibitors or mTOR Inhibitors
12/08/2011	US20110300186 Functionalized Nano- and Micro-materials for Medical Therapies
12/08/2011	US20110300184 Pharmaceutical compositions for treating or preventing bone conditions
12/08/2011	US20110300167 Cxcr5 receptor compounds
12/08/2011	US20110300161 Methods for the Treatment and the Prognostic Assessment of Malignant Pleural Mesothelioma
12/08/2011	US20110300160 Sulfation of wnt pathway proteins
12/08/2011	US20110300159 Sulfonated Sclerostin, antibodies, epitopes and methods for identification and use therefor
12/08/2011	US20110300154 Treatment of airway hyperreactivity
12/08/2011	US20110300150 Compositions and methods for treatment of autoimmune and other disease
12/08/2011	US20110300148 Il-4-derived peptides for modulation of the chronic inflammatory response and treatment of autoimmune diseases
12/08/2011	US20110300147 Inhibiting tumor cell invasion, metastasis and angiogenesis
12/08/2011	US20110300142 Use of zeburaline for the treatment of autoimmune diseases or immune rejection of transplants
12/08/2011	US20110300141 Novel Alphabeta-Binding protein and its peptide derivatives and uses thereof
12/08/2011	US20110300137 Use of lumefantrine and related compounds in the treatment of cancer
12/08/2011	US20110300132 4-aminoquinazoline prodrugs
12/08/2011	US20110300130 Impaired wound healing compositions and treatments
12/08/2011	US20110300128 Use of foxp2 as a marker for abnormal lymphocytes and as a target for therapy of disorders associated with abnormal lymphocytes
12/08/2011	US20110300125 Compositions and methods for combined therapy of disease
12/08/2011	US20110300124 Soaking agent for the treatment of hemorrhoids and method of use
12/08/2011	US20110300123 Pharmacological vitreolysis
12/08/2011	US20110300122 Method for treating a patient

1 ... 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 ... 3163